# Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

> **NCT04645667** · — · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 38 (actual)

## Conditions studied

- Acute GVHD

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT04645667
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-10-15
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645667, "Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04645667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*